Analysts expect Immunic, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 6,563.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.20 M | 21.59 M | ||||||||||
| Low Estimate | 5,966.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.56 M | 18.70 M | ||||||||||
| Consensus Estimate | 6,265.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.88 M | 20.14 M |
Analysts expect Immunic, Inc. to report earnings per share of -0.99 for Q3 26, against a range of -1.04 to -0.94. The most recent reported quarter, Q2 26, came in at -0.80, a 29.8% beat against the -1.14 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.40 | -2.50 | -2.50 | -2.00 | -1.30 | -1.00 | -1.08 | -0.80 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.92 | -2.18 | -2.13 | -1.51 | -1.40 | -0.80 | -0.58 | -1.08 | -0.94 | -0.73 | -0.56 | -0.65 | -0.42 | -0.31 | -0.68 | -0.65 | ||||||||||
| Low Estimate | -2.30 | -2.62 | -2.43 | -1.73 | -1.62 | -0.96 | -0.70 | -1.20 | -1.04 | -0.81 | -0.62 | -0.71 | -0.50 | -0.35 | -0.78 | -0.75 | ||||||||||
| Consensus Estimate | -2.11 | -2.40 | -2.28 | -1.62 | -1.51 | -0.88 | -0.64 | -1.14 | -0.99 | -0.77 | -0.59 | -0.68 | -0.46 | -0.33 | -0.73 | -0.70 |
Pull Wall Street consensus for Immunic, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IMUX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IMUX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IMUX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();